<DOC>
	<DOCNO>NCT00000684</DOCNO>
	<brief_summary>To determine safety effectiveness dextran sulfate administer intravenously maximum tolerate dose ( MTD ) treatment HIV infection AIDS patient . The effect dextran sulfate platelet survival also assess 3 patient help determine mechanism thrombocytopenia ( low platelet ) note patient receive intravenous dextran sulfate study . Dextran sulfate appear inhibit HIV experiment test tube , study conduct human determine effect HIV dextran sulfate give orally conclusive . It hop study show dextran sulfate administer intravenously</brief_summary>
	<brief_title>Continuous High-Dose Intravenous Dextran Sulfate Human Immunodeficiency Virus-Infected Individuals</brief_title>
	<detailed_description>Dextran sulfate appear inhibit HIV experiment test tube , study conduct human determine effect HIV dextran sulfate give orally conclusive . It hop study show dextran sulfate administer intravenously antiviral effect patient infected HIV . Following test evaluation , patient hospitalize 14 day . They admit hospital afternoon , start next morning , receive continuous infusion dextran sulfate intravenous line 14 day . The infusion adjust maintain activate partial thromboplastin time ( APTT ) 50 65 second . Blood withdraw 5 time first day patient receive dextran sulfate least day thereafter safety . Patients ' clinical condition , blood clotting , blood platelet monitor closely .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Acetaminophen . Patients must : Clinically document AIDS AIDSrelated complex ( ARC ) define CDC group IVA history finding define CDC group IV subgroup C2 : oral candidiasis , oral hairy leukoplakia , multidermatomal herpes zoster , recurrent nontyphoidal Salmonella bacteremia , nocardiosis . Prior Medication : Allowed : Acetaminophen . Exclusion Criteria Concurrent Treatment : Excluded : Intramuscular injection . Patients exclude study follow reason : Acute illness require hospitalization antiviral drug therapy treatment . Volunteers take antiviral medication , anticoagulant , antiplatelet medication , nonsteroidal antiinflammatory drug , except acetaminophen , within 2 week study entry , anticipate need medication study . Positive stool guaiac screening . Disorders coagulation know contraindication anticoagulation , include limited gastrointestinal serious bleeding , major trauma surgery within past 2 month , stroke suspicion central nervous system ( CNS ) bleeding , Kaposi sarcoma ( without prove gastrointestinal involvement ) , know CNS lesion might prone bleed . Allergy dextran sulfate heparin . Acute asymptomatic HIV infection . Prior Medication : Excluded : Antiviral medication . Anticoagulants . Antiplatelet medication . Any nonsteroidal antiinflammatory drug ( except acetaminophen ) . Prior Treatment : Excluded : Hospitalization acute illness . Patients may follow disease symptom : Allergy dextran sulfate heparin . Acute asymptomatic HIV infection . Acute illness require hospitalization . Chronic anemia require transfusion within past month . Disorders coagulation know contraindication anticoagulation , include limited gastrointestinal serious bleeding , major trauma surgery within past 2 month , stroke suspicion central nervous system ( CNS ) bleeding , Kaposi 's sarcoma , know CNS lesion might prone bleed .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Infusions , Intravenous</keyword>
	<keyword>Dextran Sulfate</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>